Novel C-1 substituted cocaine analogs unlike cocaine or benztropine

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 2, 2012, Pages 413-425

  Reith, Maarten E A ^a   Ali, Solav ^a   Hashim, Audrey ^b   Sheikh, Imran S ^c   Theddu, Naresh ^d   Gaddiraju, Narendra V ^d   Mehrotra, Suneet ^e   Schmitt, Kyle C ^a   Murray, Thomas F ^e   Sershen, Henry ^b   Unterwald, Ellen M ^c   Davis, Franklin A ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Temple University   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYLCOCAINE; 1 METHYLCOCAINE; 1 PENTYLCOCAINE; 1 PHENYLCOCAINE; 1 PROPYLCOCAINE; BENZATROPINE; CITALOPRAM; COCAINE; COCAINE DERIVATIVE; DESIPRAMINE; DOPAMINE TRANSPORTER; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; SODIUM ION; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BRAIN NERVE CELL; CONTROLLED STUDY; DEPRESSION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; FORCED SWIMMING TEST; HUMAN; HUMAN CELL; LOCOMOTION; MALE; MOLECULAR DOCKING; MOUSE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; SODIUM TRANSPORT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BENZTROPINE; BRAIN; COCAINE; CONDITIONING, OPERANT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; INDICATORS AND REAGENTS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEOCORTEX; NEURONS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PREGNANCY; PROTEIN BINDING; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SODIUM; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP; SWIMMING; VERATRIDINE;

EID: 84867607636     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.193771     Document Type: Article

References (60)

1. Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, and Newman AH (1997) Novel N-substituted 3α-[bis(4′-fluorophenyl)methoxy] tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40:4329-4339. (Pubitemid 28042312)
2. Bardo MT and Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43. (Pubitemid 32127902)
3. Benuck M, Lajtha A, and Reith ME (1987) Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243:144-149. (Pubitemid 17162710)
4. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11:780-789.
5. Bisgaard H, Larsen MA, Mazier S, Beuming T, Newman AH, Weinstein H, Shi L, Loland CJ, and Gether U (2011) The binding sites for benztropines and dopamine in the dopamine transporter overlap. Neuropharmacology 60:182-190.
6. Buck KJ and Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci U S A 91:12584-12588.
7. Campbell VC, Kopajtic TA, Newman AH, and Katz JL (2005) Assessment of the influence of histaminergic actions on cocaine-like effects of 3α-diphenylmethoxytropane analogs. J Pharmacol Exp Ther 315:631-640. (Pubitemid 41500728)
8. Cao Z, George J, Gerwick WH, Baden DG, Rainier JD, and Murray TF (2008) Influence of lipid-soluble gating modifier toxins on sodium influx in neocortical neurons. J Pharmacol Exp Ther 326:604-613.
9. Carroll FI, Lewin AH, Boja JW, and Kuhar MJ (1992) Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J Med Chem 35:969-981.
10. Castagne V, Moser P, Roux S, and Porsolt RD (2011) Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci Chapter 8:Unit 8.10A.
11. Chen N, Zhen J, and Reith ME (2004) Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR 12909 and benztropine as opposed to cocaine. J Neurochem 89:853-864. (Pubitemid 38684733)
12. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, et al. (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 103:9333-9338. (Pubitemid 43902577)
13. Cheng T, Zhao Y, Li X, Lin F, Xu Y, Zhang X, Li Y, Wang R, and Lai L (2007) Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model 47:2140-2148. (Pubitemid 350275080)
14. Clarke RL, Daum SJ, Gambino AJ, Aceto MD, Pearl J, Levitt M, Cumiskey WR, and Bogado EF (1973) Compounds affecting the central nervous system. 4. 3 β-phenyltropane-2-carboxylic esters and analogues. J Med Chem 16:1260-1267.
15. Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, and Kuhar MJ (1992) Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. J Pharmacol Exp Ther 260:1174-1179.
16. Cook CD, Carroll FI, and Beardsley PM (1998) Separation of the locomotor stimulant and discriminative stimulus effects of cocaine by its C-2 phenyl ester analog, RTI-15. Drug Alcohol Depend 50:123-128. (Pubitemid 28271626)
17. Davis FA (2006) Adventures in sulfur-nitrogen chemistry. J Org Chem 71:8993-9003.
18. Davis FA, Gaddiraju NV, Theddu N, Hummel JR, Kondaveeti SK, and Zdilla MJ (2012) Enantioselective synthesis of cocaine C-1 analogs using sulfinimines (Nsulfinyl imines). J Org Chem 77:2345-2359.
19. Davis FA, Theddu N, and Edupuganti R (2010) Asymmetric total synthesis of (S)-(+)-cocaine and the first synthesis of cocaine C-1 analogues from N-sulfinyl β-amino ester ketals. Org Lett 12:4118-4121.
20. Deffois A, Fage D, and Carter C (1996) Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci Lett 220:117-120. (Pubitemid 26426598)
21. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, and Katz JL (2005) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889-1893. (Pubitemid 40289393)
22. Dutta AK, Ghosh B, Biswas S, and Reith ME (2008) D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action. Eur J Pharmacol 589:73-79.
23. Eisener-Dorman AF, Grabowski-Boase L, and Tarantino LM (2011) Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice. Behav Brain Funct 7:29.
24. Eshleman AJ, Neve RL, Janowsky A, and Neve KA (1995) Characterization of a recombinant human dopamine transporter in multiple cell lines. J Pharmacol Exp Ther 274:276-283.
25. Gopishetty B, Hazeldine S, Santra S, Johnson M, Modi G, Ali S, Zhen J, Reith M, and Dutta A (2011) Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents. J Med Chem 54:2924-2932.
26. Gu H, Wall SC, and Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130. (Pubitemid 24217896)
27. Herin DV, Rush CR, and Grabowski J (2010) Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann NY Acad Sci 1187:76-100.
28. Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, and Katz JL (2011) Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. J Pharmacol Exp Ther 339:662-677.
29. Howell LL, Carroll FI, Votaw JR, Goodman MM, and Kimmel HL (2007) Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:757-765. (Pubitemid 46147957)
30. Jabba SV, Prakash A, Dravid SM, Gerwick WH, and Murray TF (2010) Antillatoxin, a novel lipopeptide, enhances neurite outgrowth in immature cerebrocortical neurons through activation of voltage-gated sodium channels. J Pharmacol Exp Ther 332:698-709.
31. Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309:650-660. (Pubitemid 38542619)
32. Katz JL, Su TP, Hiranita T, Hayashi T, Tanda G, Kopajtic T, and Tsai SY (2011) A role for σ receptors in stimulant self administration and addiction. Pharmaceuticals 4:880-914.
33. Li SM, Kopajtic TA, O'Callaghan MJ, Agoston GE, Cao J, Newman AH, and Katz JL (2011) N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. J Pharmacol Exp Ther 336:575-585.
34. Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, and Gether U (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73:813-823. (Pubitemid 351397886)
35. Matthews JC and Collins A (1983) Interactions of cocaine and cocaine congeners with sodium channels. Biochem Pharmacol 32:455-460. (Pubitemid 13184549)
36. Morton D and Stockman RA (2006) Chiral non-racemic sulfinimines: versatile reagents for asymmetric synthesis. Tetrahedron 62:8869-8905. (Pubitemid 44218983)
37. Nestler EJ and Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159. (Pubitemid 44192421)
38. Newman AH and Katz JL (2009) Atypical dopamine uptake inhibitors that provide clues about cocaine's mechanism at the dopamine transporter. Top Med Chem 4:95-129.
39. Nyola A, Karpowich NK, Zhen J, Marden J, Reith ME, and Wang DN (2010) Substrate and drug binding sites in LeuT. Curr Opin Struct Biol 20:415-422.
40. Porsolt RD, Bertin A, and Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336. (Pubitemid 8225714)
41. Rapoport SI (1992) Drug delivery to the brain: barrier modification and drug modification methodologies. NIDA Res Monogr 120:121-137.
42. Reith ME, Benuck M, and Lajtha A (1987) Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J Pharmacol Exp Ther 243:281-287. (Pubitemid 17162729)
43. Reith ME, Berfield JL, Wang LC, Ferrer JV, and Javitch JA (2001) The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276:29012-29018.
44. Reith ME, Meisler BE, Sershen H, and Lajtha A (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123-1129. (Pubitemid 16075529)
45. Reith ME, Wang LC, and Dutta AK (2005) Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity. J Neurosci Methods 143:87-94. (Pubitemid 40348792)
46. Rothman RB and Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 1074:245-260. (Pubitemid 44532828)
47. Rothman RB, Baumann MH, Prisinzano TE, and Newman AH (2008) Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol 75:2-16. (Pubitemid 350235399)
48. Schmitt KC, Mamidyala S, Biswas S, Dutta AK, and Reith ME (2010) Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate-binding sites in a single transporter. J Neurochem 112: 1605-1618.
49. Schmitt KC and Reith ME (2011) The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS ONE 6:e25790.
50. Schmitt KC, Zhen J, Kharkar P, Mishra M, Chen N, Dutta AK, and Reith ME (2008) Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. J Neurochem 107:928-940.
51. Senanayake CH, Krishnamurthy D, Lu ZH, Han Z, and Gallou I (2005) Enantiopure sulfoxides and sulfinamides: recent developments in their stereoselective synthesis and applications to asymmetric synthesis. Aldrichm Acta 38:93-104. (Pubitemid 41692342)
52. Sershen H, Hashim A, and Vadasz C (2002) Strain and sex differences in repeated ethanol treatment-induced motor activity in quasi-congenic mice. Genes Brain Behav 1:156-165. (Pubitemid 36717673)
53. Shan J, Javitch JA, Shi L, and Weinstein H (2011) The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter. PLoS ONE 6:e16350.
54. Shearer J (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev 27:301-308.
55. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99.
56. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, and Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119:376-384.
57. Stewart JW, McGrath PJ, Deliyannides RA, and Quitkin FM (2009) Does dual antidepressant therapy as initial treatment hasten and increase remission from depression? J Psychiatr Pract 15: 337-345.
58. Thomsen M, Han DD, Gu HH, and Caine SB (2009) Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 331:204-211.
59. Zhou P, Chen BC, and Davis FA (2004) Recent advances in asymmetric reaction using sulfinimines (N-sulfinyl imines). Tetrahedron 60:8003-8030. (Pubitemid 39094318)
60. Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, and Wang DN (2007) LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317:1390-1393. (Pubitemid 47417479)